Copyright Reports & Markets. All rights reserved.

Global Tetanus Vaccine Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Tetanus Vaccine Market Overview

      • 1.1 Product Overview and Scope of Tetanus Vaccine
      • 1.2 Tetanus Vaccine Segment by Type
        • 1.2.1 Global Tetanus Vaccine Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Diphtheria and tetanus (DT) vaccines
        • 1.2.3 Diphtheria, tetanus, and pertussis (whooping cough) (DTaP) vaccines
        • 1.2.4 Tetanus and diphtheria (Td) vaccines
        • 1.2.5 Tetanus, diphtheria, and pertussis (Tdap) vaccines
      • 1.3 Tetanus Vaccine Segment by Application
        • 1.3.1 Tetanus Vaccine Consumption Comparison by Application (2014-2025)
        • 1.3.2 Adult
        • 1.3.3 Pediatric
      • 1.4 Global Tetanus Vaccine Market by Region
        • 1.4.1 Global Tetanus Vaccine Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Tetanus Vaccine Market Size
        • 1.5.1 Global Tetanus Vaccine Revenue (2014-2025)
        • 1.5.2 Global Tetanus Vaccine Production (2014-2025)

      2 Global Tetanus Vaccine Market Competition by Manufacturers

      • 2.1 Global Tetanus Vaccine Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Tetanus Vaccine Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Tetanus Vaccine Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Tetanus Vaccine Production Sites, Area Served, Product Types
      • 2.5 Tetanus Vaccine Market Competitive Situation and Trends
        • 2.5.1 Tetanus Vaccine Market Concentration Rate
        • 2.5.2 Tetanus Vaccine Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Tetanus Vaccine Production Market Share by Regions

      • 3.1 Global Tetanus Vaccine Production Market Share by Regions
      • 3.2 Global Tetanus Vaccine Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Tetanus Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Tetanus Vaccine Production
        • 3.4.1 North America Tetanus Vaccine Production Growth Rate (2014-2019)
        • 3.4.2 North America Tetanus Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Tetanus Vaccine Production
        • 3.5.1 Europe Tetanus Vaccine Production Growth Rate (2014-2019)
        • 3.5.2 Europe Tetanus Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Tetanus Vaccine Production (2014-2019)
        • 3.6.1 China Tetanus Vaccine Production Growth Rate (2014-2019)
        • 3.6.2 China Tetanus Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Tetanus Vaccine Production (2014-2019)
        • 3.7.1 Japan Tetanus Vaccine Production Growth Rate (2014-2019)
        • 3.7.2 Japan Tetanus Vaccine Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Tetanus Vaccine Consumption by Regions

      • 4.1 Global Tetanus Vaccine Consumption by Regions
      • 4.2 North America Tetanus Vaccine Consumption (2014-2019)
      • 4.3 Europe Tetanus Vaccine Consumption (2014-2019)
      • 4.4 China Tetanus Vaccine Consumption (2014-2019)
      • 4.5 Japan Tetanus Vaccine Consumption (2014-2019)

      5 Global Tetanus Vaccine Production, Revenue, Price Trend by Type

      • 5.1 Global Tetanus Vaccine Production Market Share by Type (2014-2019)
      • 5.2 Global Tetanus Vaccine Revenue Market Share by Type (2014-2019)
      • 5.3 Global Tetanus Vaccine Price by Type (2014-2019)
      • 5.4 Global Tetanus Vaccine Production Growth by Type (2014-2019)

      6 Global Tetanus Vaccine Market Analysis by Applications

      • 6.1 Global Tetanus Vaccine Consumption Market Share by Application (2014-2019)
      • 6.2 Global Tetanus Vaccine Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Tetanus Vaccine Business

      • 7.1 GlaxoSmithKline plc
        • 7.1.1 GlaxoSmithKline plc Tetanus Vaccine Production Sites and Area Served
        • 7.1.2 Tetanus Vaccine Product Introduction, Application and Specification
        • 7.1.3 GlaxoSmithKline plc Tetanus Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Pfizer,Inc
        • 7.2.1 Pfizer,Inc Tetanus Vaccine Production Sites and Area Served
        • 7.2.2 Tetanus Vaccine Product Introduction, Application and Specification
        • 7.2.3 Pfizer,Inc Tetanus Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Merck & Co.,Inc
        • 7.3.1 Merck & Co.,Inc Tetanus Vaccine Production Sites and Area Served
        • 7.3.2 Tetanus Vaccine Product Introduction, Application and Specification
        • 7.3.3 Merck & Co.,Inc Tetanus Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Sanofi Pasteur SA
        • 7.4.1 Sanofi Pasteur SA Tetanus Vaccine Production Sites and Area Served
        • 7.4.2 Tetanus Vaccine Product Introduction, Application and Specification
        • 7.4.3 Sanofi Pasteur SA Tetanus Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Biological E
        • 7.5.1 Biological E Tetanus Vaccine Production Sites and Area Served
        • 7.5.2 Tetanus Vaccine Product Introduction, Application and Specification
        • 7.5.3 Biological E Tetanus Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Dano Vaccine &Biological Pvt.Ltd.,
        • 7.6.1 Dano Vaccine &Biological Pvt.Ltd., Tetanus Vaccine Production Sites and Area Served
        • 7.6.2 Tetanus Vaccine Product Introduction, Application and Specification
        • 7.6.3 Dano Vaccine &Biological Pvt.Ltd., Tetanus Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Panera
        • 7.7.1 Panera Tetanus Vaccine Production Sites and Area Served
        • 7.7.2 Tetanus Vaccine Product Introduction, Application and Specification
        • 7.7.3 Panera Tetanus Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Shantha Biotechnics Ltd
        • 7.8.1 Shantha Biotechnics Ltd Tetanus Vaccine Production Sites and Area Served
        • 7.8.2 Tetanus Vaccine Product Introduction, Application and Specification
        • 7.8.3 Shantha Biotechnics Ltd Tetanus Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served

      8 Tetanus Vaccine Manufacturing Cost Analysis

      • 8.1 Tetanus Vaccine Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Tetanus Vaccine
      • 8.4 Tetanus Vaccine Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Tetanus Vaccine Distributors List
      • 9.3 Tetanus Vaccine Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Tetanus Vaccine Market Forecast

      • 11.1 Global Tetanus Vaccine Production, Revenue Forecast
        • 11.1.1 Global Tetanus Vaccine Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Tetanus Vaccine Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Tetanus Vaccine Price and Trend Forecast (2019-2025)
      • 11.2 Global Tetanus Vaccine Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Tetanus Vaccine Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Tetanus Vaccine Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Tetanus Vaccine Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Tetanus Vaccine Production, Revenue Forecast (2019-2025)
      • 11.3 Global Tetanus Vaccine Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Tetanus Vaccine Consumption Forecast (2019-2025)
        • 11.3.2 Europe Tetanus Vaccine Consumption Forecast (2019-2025)
        • 11.3.3 China Tetanus Vaccine Consumption Forecast (2019-2025)
        • 11.3.4 Japan Tetanus Vaccine Consumption Forecast (2019-2025)
      • 11.4 Global Tetanus Vaccine Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Tetanus Vaccine Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Tetanus vaccine, also known as tetanus toxoid (TT), is an inactive vaccine used to prevent tetanus. During childhood five doses are recommended, with a sixth given during adolescence. Additional doses every 10 years are recommended. After three doses almost everyone is initially immune. In those who are not up to date on their tetanus immunization a booster should be given within 48 hours of an injury. In those with high risk injuries who are not fully immunized tetanus antitoxin may also be recommended. Making sure women who are pregnant are up to date on their tetanus immunization and, if not, immunizing them can prevent neonatal tetanus.

        The vaccine is very safe including during pregnancy and in those with HIV/AIDS. Redness and pain at the site of injection occur in between 25% and 85% of people. Fever, feeling tired, and minor muscles pains occur in less than 10% of people. Severe allergic reactions occur in less than one in 100,000 people.

        A number of vaccine combinations include the tetanus vaccine such as DTaP and Tdap which contain diphtheria, tetanus, and pertussis vaccine, and DT and Td which contain diphtheria and tetanus vaccine. DTaP and DT are given to children less than seven years old while Tdap and Td are given to those seven years old and older. The lowercase d and p denote lower strengths of diphtheria and pertussis vaccines.

        The tetanus vaccine was developed in 1924 and became available in the United States in the 1940s. Its use resulted in a 95% decrease in the rate of tetanus. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is between 0.17 and 0.65 USD per dose as of 2014.In the United States a course of tetanus vaccine is between 25 and 50 USD.

        The global Tetanus Vaccine market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Tetanus Vaccine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Tetanus Vaccine market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        GlaxoSmithKline plc
        Pfizer,Inc
        Merck & Co.,Inc
        Sanofi Pasteur SA
        Biological E
        Dano Vaccine &Biological Pvt.Ltd.,
        Panera
        Shantha Biotechnics Ltd

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Diphtheria and tetanus (DT) vaccines
        Diphtheria, tetanus, and pertussis (whooping cough) (DTaP) vaccines
        Tetanus and diphtheria (Td) vaccines
        Tetanus, diphtheria, and pertussis (Tdap) vaccines

        Segment by Application
        Adult
        Pediatric

        Buy now